ISIN | CH0226274246 |
---|---|
Valor Number | 22627424 |
Bloomberg Global ID | SWICHA SW |
Fund Name | UBS ETF (CH) - UBS MSCI Switzerland ETF CHF dis |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland | |
Distributor(s) |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Asset Class | Equities |
EFC Category | Equity Switzerland |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The sub-fund aims to replicate the price and return performance of the MSCI Switzerland Index (“MSCI Switzerland”) gross of fees. The sub-fund does not qualify as sustainable and is not managed sustainably. |
Peculiarities |
Current Price * | 21.21 CHF | 12.09.2025 |
---|---|---|
Previous Price * | 21.35 CHF | 11.09.2025 |
52 Week High * | 21.93 CHF | 03.03.2025 |
52 Week Low * | 18.41 CHF | 09.04.2025 |
NAV * | 21.21 CHF | 12.09.2025 |
Issue Price * | 21.21 CHF | 12.09.2025 |
Redemption Price * | 21.21 CHF | 12.09.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 714,874,965 | |
Unit/Share Assets *** | 714,874,965 | |
Trading Information SIX |
YTD Performance | +9.00% |
31.12.2024 - 12.09.2025
31.12.2024 12.09.2025 |
---|---|---|
1 month | +2.76% |
12.08.2025 - 12.09.2025
12.08.2025 12.09.2025 |
3 months | -0.43% |
12.06.2025 - 12.09.2025
12.06.2025 12.09.2025 |
6 months | -1.51% |
12.03.2025 - 12.09.2025
12.03.2025 12.09.2025 |
1 year | +5.91% |
12.09.2024 - 12.09.2025
12.09.2024 12.09.2025 |
2 years | +16.96% |
12.09.2023 - 12.09.2025
12.09.2023 12.09.2025 |
3 years | +19.56% |
12.09.2022 - 12.09.2025
12.09.2022 12.09.2025 |
5 years | +29.93% |
14.09.2020 - 12.09.2025
14.09.2020 12.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | 0.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date | 12.09.2025 |
Novartis AG Registered Shares | 13.09% | |
---|---|---|
Nestle SA | 12.95% | |
Roche Holding AG | 12.78% | |
UBS Group AG Registered Shares | 6.93% | |
ABB Ltd | 6.06% | |
Zurich Insurance Group AG | 5.74% | |
Compagnie Financiere Richemont SA Class A | 5.45% | |
Swiss Re AG | 2.86% | |
Lonza Group Ltd | 2.67% | |
Holcim Ltd | 2.35% | |
Last data update | 10.09.2025 |
TER | 0.21% |
---|---|
TER date | 30.06.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.60% |
Ongoing Charges *** | 0.20% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |